Are Wall Street Analysts Predicting Medtronic Stock Will Climb or Sink?

With a market cap of around $132 billion, Medtronic plc (MDT) is a global medical technology company that develops, manufactures, and sells device-based therapies to healthcare providers and patients worldwide. It operates across cardiovascular, neuroscience, medical-surgical, and diabetes care, offering innovative solutions that address a wide range of chronic and acute conditions.

Shares of the Galway, Ireland-based company have lagged behind the broader market over the past 52 weeks. MDT stock has increased 13.5% over this time frame, while the broader S&P 500 Index ($SPX) has gained 15.2%. However, the stock has returned 7.3% on a YTD basis, outpacing SPX's 1.6% rise.